Boehringer to pay $13.5 million to resolve U.S. states' drug probe

Reuters News
Posted: Dec 20, 2017 12:16 PM

(Reuters) - Boehringer Ingelheim will pay $13.5 million to resolve claims by state attorneys general that the pharmaceutical company used deceptive and misleading marketing to promote the use of four of its drugs.

The settlement was announced on Wednesday by attorneys general in 50 states to resolve allegations centered on how the drugmaker marketed its prescription drugs Aggrenox, Micardis, Atrovent and Combivent.

(Reporting by Nate Raymond in Boston)